<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01652040</url>
  </required_header>
  <id_info>
    <org_study_id>B7867-W</org_study_id>
    <nct_id>NCT01652040</nct_id>
  </id_info>
  <brief_title>Resistance Training and Testosterone After Spinal Cord Injury</brief_title>
  <official_title>Effects of Evoked Resistance Training and Testosterone After Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this proposal is to investigate the efficacy of a complimentary approach of
      evoked resistance training and testosterone replacement therapy on the changes in body
      composition and metabolic profile after SCI. The proposed method could become a recommended
      and simple intervention especially for individuals with limited access and poor tolerance to
      exercise. The rationale is based on the evidence that individuals with SCI experience decline
      in anabolic hormones which may be responsible for the deterioration in body composition and
      metabolic profiles and leads to increase obesity, type 2 diabetes mellitus, dyslipidemia and
      subsequently cardiovascular disease. The designed study will provide explanation to the
      adaptations in the energy source of the muscle cells in response to training.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individuals with spinal cord injury (SCI) are at a lifelong risk of increasing obesity and
      several chronic metabolic disorders such as glucose intolerance, insulin resistance and
      dyslipidemia secondary to deterioration in body composition. Within few weeks of injury,
      there are significant decrease in whole body fat-free mass (FFM), particularly lower
      extremity skeletal muscle mass and subsequent increase in fat mass (FM). Resistance training
      (RT) is an important type of exercise that has been shown to induce positive physiological
      adaptations such as increasing lean mass and reducing metabolic disorders in other clinical
      populations.

      In a pilot work, the investigators provided evidence that evoked RT using surface
      neuromuscular electrical stimulation (NMES) for knee extensor muscle group resulted in
      significant increase skeletal muscle cross-sectional area (CSA), reduction in % leg FM and a
      trend towards decrease in visceral adipose tissue (VAT) CSA. The favorable adaptations in
      body composition were associated with decrease in plasma insulin area under the curve and
      plasma triglycerides. The investigators attributed the adaptations in body composition and
      metabolic profile to an associated increase in plasma insulin-like growth factor (IGF-1). The
      investigators concluded that twelve weeks of evoked RT targeted towards evoking skeletal
      muscle hypertrophy could result in significant body composition and metabolic adaptations in
      individuals with SCI.

      It is unclear if a longer RT program greater than 12 weeks would provide additional benefits
      to Veterans with SCI. It is also unknown whether enhancing the decline anabolic homeostasis
      by providing testosterone (T) replacement therapy (TRT) would reverse body composition and
      metabolic profile changes in Veterans with SCI. The major research goal of this proposal is
      to investigate the effects of 16 weeks of evoked RT+TRT vs. TRT on body composition (muscle
      CSA, VAT, %FM) and the metabolic profiles (glucose and lipid metabolism) in individuals with
      motor complete SCI. To address this goal, surface NMES accompanied with ankle weights will be
      conducted twice weekly to exercise the knee extensor skeletal muscle groups from sitting
      position. After 4 weeks of delayed entry approach, participants (n =24) will be randomly
      assigned into RT+TRT (n =12) or TRT (n =12) groups. The TRT will be provided via transdermal
      T patches that will be alternated on both shoulders over the course of the study. The
      investigators also propose to study the effects of detraining on body composition and
      metabolic profiles.

      The research plan includes three specific aims

      Specific aim 1 will demonstrate the effects of NMES RT and/or Testosterone patches (Tp) on
      the CSA of thighs and legs skeletal muscle groups, percentage FFM, and the CSA of VAT,
      intramuscular fat and percentage FM after 16 weeks of training+Tp and 16 weeks of detraining.

      Specific aim 2 will determine the changes in metabolic milieu (resting energy expenditure,
      glucose homeostasis, lipid profile, free fatty acids, serum total and free testosterone and
      IGF-1), and cytokines (c-reactive protein, tumor necrosis factor alpha and IL-6 as
      inflammatory biomarkers) after 16 weeks of training+Tp and detraining.

      Specific aim 3 will determine if 16 weeks of evoked RT and Tp will increase GLUT-4
      concentration, muscle IGF-1 and peroxisome-proliferator-activated receptor-gamma co-activator
      1 (PGC-1) expressions, altered fiber type distribution and enhance the mitochondrial
      enzymatic activities (electron transport chain) compared to Tp only.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2, 2012</start_date>
  <completion_date type="Actual">December 30, 2017</completion_date>
  <primary_completion_date type="Actual">December 30, 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Composition</measure>
    <time_frame>16 weeks</time_frame>
    <description>Changes in body composition fat mass</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic Profile</measure>
    <time_frame>16 weeks</time_frame>
    <description>Basal Metabolic Rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>RT+Tp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resistance training using electrical stimulation and ankle weights and Testosterone patches</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Applying Testosterone patches</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Resistance Training and Testosterone Patches</intervention_name>
    <description>We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.</description>
    <arm_group_label>RT+Tp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone Patches</intervention_name>
    <description>The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.</description>
    <arm_group_label>Tp</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male with Spinal Cord Injury

          -  Between 18-50 years old

          -  BMI &lt; 30 Kg/m2

          -  Traumatic motor complete C5-L2 level of injury

          -  American Spinal Injury Classification (A and B; i.e. motor deficit below the level of
             injury)

        Exclusion Criteria:

          -  Cardiovascular disease

          -  Uncontrolled type II DM and those on insulin

          -  Pressures sores stage 2 or greater

          -  Supra-physiological T level

          -  Hematocrit above 50%

          -  Urinary tract infection or symptoms
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashraf Gorgey, PhD PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hunter Holmes McGuire VA Medical Center, Richmond, VA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center, Richmond, VA</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gorgey AS, Khalil RE, Gill R, O'Brien LC, Lavis T, Castillo T, Cifu DX, Savas J, Khan R, Cardozo C, Lesnefsky EJ, Gater DR, Adler RA. Effects of Testosterone and Evoked Resistance Exercise after Spinal Cord Injury (TEREX-SCI): study protocol for a randomised controlled trial. BMJ Open. 2017 Apr 4;7(4):e014125. doi: 10.1136/bmjopen-2016-014125.</citation>
    <PMID>28377392</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Moore PD, Wade RC, Gill RS, Lavis T, Adler RA. Disruption in bone marrow fat may attenuate testosterone action on muscle size after spinal cord injury: a case report. Eur J Phys Rehabil Med. 2017 Aug;53(4):625-629. doi: 10.23736/S1973-9087.17.04452-5. Epub 2017 Mar 13.</citation>
    <PMID>28290190</PMID>
  </reference>
  <reference>
    <citation>Wade RC, Gorgey AS. Anthropometric prediction of skeletal muscle cross-sectional area in persons with spinal cord injury. J Appl Physiol (1985). 2017 May 1;122(5):1255-1261. doi: 10.1152/japplphysiol.01042.2016. Epub 2017 Mar 2.</citation>
    <PMID>28255089</PMID>
  </reference>
  <reference>
    <citation>O'Brien LC, Wade RC, Segal L, Chen Q, Savas J, Lesnefsky EJ, Gorgey AS. Mitochondrial mass and activity as a function of body composition in individuals with spinal cord injury. Physiol Rep. 2017 Feb;5(3). pii: e13080. doi: 10.14814/phy2.13080.</citation>
    <PMID>28193782</PMID>
  </reference>
  <reference>
    <citation>Moore PD, Gorgey AS, Wade RC, Khalil RE, Lavis TD, Khan R, Adler RA. Neuromuscular electrical stimulation and testosterone did not influence heterotopic ossification size after spinal cord injury: A case series. World J Clin Cases. 2016 Jul 16;4(7):172-6. doi: 10.12998/wjcc.v4.i7.172.</citation>
    <PMID>27458592</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Caudill C, Khalil RE. Effects of once weekly NMES training on knee extensors fatigue and body composition in a person with spinal cord injury. J Spinal Cord Med. 2016;39(1):99-102. doi: 10.1179/2045772314Y.0000000293. Epub 2015 Jan 23.</citation>
    <PMID>25615403</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Mather KJ, Cupp HR, Gater DR. Effects of resistance training on adiposity and metabolism after spinal cord injury. Med Sci Sports Exerc. 2012 Jan;44(1):165-74. doi: 10.1249/MSS.0b013e31822672aa.</citation>
    <PMID>21659900</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Shepherd C. Skeletal muscle hypertrophy and decreased intramuscular fat after unilateral resistance training in spinal cord injury: case report. J Spinal Cord Med. 2010;33(1):90-5.</citation>
    <PMID>20397451</PMID>
  </reference>
  <reference>
    <citation>Khalil RE, Gorgey AS, Janisko M, Dolbow DR, Moore JR, Gater DR. The role of nutrition in health status after spinal cord injury. Aging Dis. 2013 Feb;4(1):14-22. Epub 2012 Nov 30.</citation>
    <PMID>23423356</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Dolbow DR, Cifu DX, Gater DR. Neuromuscular electrical stimulation attenuates thigh skeletal muscles atrophy but not trunk muscles after spinal cord injury. J Electromyogr Kinesiol. 2013 Aug;23(4):977-84. doi: 10.1016/j.jelekin.2013.04.007. Epub 2013 May 15.</citation>
    <PMID>23683374</PMID>
  </reference>
  <reference>
    <citation>Nightingale TE, Moore P, Harman J, Khalil R, Gill RS, Castillo T, Adler RA, Gorgey AS. Body Composition changes with Testosterone Replacement Therapy following Spinal Cord Injury and Aging. A Mini Review. J Spinal Cord Med. 2017 Aug 3:1-21. doi: 10.1080/10790268.2017.1357917. [Epub ahead of print]</citation>
    <PMID>28770686</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Lester RM, Wade RC, Khalil RE, Khan RK, Anderson ML, Castillo T. A feasibility pilot using telehealth videoconference monitoring of home-based NMES resistance training in persons with spinal cord injury. Spinal Cord Ser Cases. 2017 Jun 29;3:17039. doi: 10.1038/scsandc.2017.39. eCollection 2017.</citation>
    <PMID>29021917</PMID>
  </reference>
  <reference>
    <citation>Nightingale TE, Gorgey AS. Predicting Basal Metabolic Rate in Men with Motor Complete Spinal Cord Injury. Med Sci Sports Exerc. 2018 Jun;50(6):1305-1312. doi: 10.1249/MSS.0000000000001548.</citation>
    <PMID>29315167</PMID>
  </reference>
  <reference>
    <citation>Abilmona SM, Gorgey AS. Associations of the trunk skeletal musculature and dietary intake to biomarkers of cardiometabolic health after spinal cord injury. Clin Physiol Funct Imaging. 2018 Feb 6. doi: 10.1111/cpf.12505. [Epub ahead of print]</citation>
    <PMID>29405604</PMID>
  </reference>
  <reference>
    <citation>Rankin KC, O'Brien LC, Gorgey AS. Quantification of trunk and android lean mass using dual energy x-ray absorptiometry compared to magnetic resonance imaging after spinal cord injury. J Spinal Cord Med. 2018 Feb 20:1-9. doi: 10.1080/10790268.2018.1438879. [Epub ahead of print]</citation>
    <PMID>29461936</PMID>
  </reference>
  <reference>
    <citation>McCauley LS, Sumrell RM, Gorgey AS. Anthropometric Prediction of Visceral Adipose Tissue in Persons With Motor Complete Spinal Cord Injury. PM R. 2018 Feb 21. pii: S1934-1482(18)30098-4. doi: 10.1016/j.pmrj.2018.02.007. [Epub ahead of print]</citation>
    <PMID>29474998</PMID>
  </reference>
  <reference>
    <citation>Gorgey AS, Cirnigliaro CM, Bauman WA, Adler RA. Estimates of the precision of regional and whole body composition by dual-energy x-ray absorptiometry in persons with chronic spinal cord injury. Spinal Cord. 2018 Mar 6. doi: 10.1038/s41393-018-0079-x. [Epub ahead of print]</citation>
    <PMID>29511310</PMID>
  </reference>
  <reference>
    <citation>O'Brien LC, Graham ZA, Chen Q, Lesnefsky EJ, Cardozo C, Gorgey AS. Plasma adiponectin levels are correlated with body composition, metabolic profiles, and mitochondrial markers in individuals with chronic spinal cord injury. Spinal Cord. 2018 Mar 20. doi: 10.1038/s41393-018-0089-8. [Epub ahead of print]</citation>
    <PMID>29559683</PMID>
  </reference>
  <results_reference>
    <citation>O'Brien LC, Chen Q, Savas J, Lesnefsky EJ, Gorgey AS. Skeletal muscle mitochondrial mass is linked to lipid and metabolic profile in individuals with spinal cord injury. Eur J Appl Physiol. 2017 Nov;117(11):2137-2147. doi: 10.1007/s00421-017-3687-9. Epub 2017 Sep 1.</citation>
    <PMID>28864949</PMID>
  </results_reference>
  <results_reference>
    <citation>Rankin KC, O'Brien LC, Segal L, Khan MR, Gorgey AS. Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury. Biomed Res Int. 2017;2017:1364818. doi: 10.1155/2017/1364818. Epub 2017 Aug 30.</citation>
    <PMID>28948164</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2012</study_first_submitted>
  <study_first_submitted_qc>July 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2012</study_first_posted>
  <results_first_submitted>March 30, 2018</results_first_submitted>
  <results_first_submitted_qc>May 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">May 3, 2018</results_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal Cord Injury</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Electrical Stimulation</keyword>
  <keyword>Testosterone</keyword>
  <keyword>Body Composition</keyword>
  <keyword>Lipid and Glucose profile</keyword>
  <keyword>Ectopic Adiposity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>RT+Tp</title>
          <description>Resistance training using electrical stimulation and ankle weights and Testosterone patches
Resistance Training and Testosterone Patches: We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.</description>
        </group>
        <group group_id="P2">
          <title>Testosterone Replacement Patches (Tp)</title>
          <description>Applying Testosterone patches
Testosterone Patches: The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Persons with motor complete AIS A or B and level of injury C5 and with age under 50 years old.</population>
      <group_list>
        <group group_id="B1">
          <title>RT+Tp</title>
          <description>Resistance training using electrical stimulation and ankle weights and Testosterone patches
Resistance Training and Testosterone Patches: We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.</description>
        </group>
        <group group_id="B2">
          <title>Testosterone Replacement Patches (Tp)</title>
          <description>Applying Testosterone patches
Testosterone Patches: The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" spread="12"/>
                    <measurement group_id="B2" value="35" spread="8"/>
                    <measurement group_id="B3" value="36" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Body Composition</title>
        <description>Changes in body composition fat mass</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RT+Tp</title>
            <description>Resistance training using electrical stimulation and ankle weights and Testosterone patches
Resistance Training and Testosterone Patches: We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.</description>
          </group>
          <group group_id="O2">
            <title>Testosteroe Replacement Patches (Tp)</title>
            <description>Applying Testosterone patches
Testosterone Patches: The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.</description>
          </group>
        </group_list>
        <measure>
          <title>Body Composition</title>
          <description>Changes in body composition fat mass</description>
          <units>percentage of fat mass</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.84" spread="10.7"/>
                    <measurement group_id="O2" value="33.4" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention (After 16 weeks)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.75" spread="10.3"/>
                    <measurement group_id="O2" value="32.12" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Metabolic Profile</title>
        <description>Basal Metabolic Rate</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RT+Tp</title>
            <description>Resistance training using electrical stimulation and ankle weights and Testosterone patches
Resistance Training and Testosterone Patches: We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.</description>
          </group>
          <group group_id="O2">
            <title>Testosterone Replacement Patches (Tp)</title>
            <description>Applying Testosterone patches
Testosterone Patches: The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.</description>
          </group>
        </group_list>
        <measure>
          <title>Metabolic Profile</title>
          <description>Basal Metabolic Rate</description>
          <units>kcal/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1525" spread="261"/>
                    <measurement group_id="O2" value="1491" spread="177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Intervention (After 16 weeks)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1665" spread="243"/>
                    <measurement group_id="O2" value="1502" spread="327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 weeks</time_frame>
      <desc>Adverse Events were monitored for skin irritation from using testosterone patches</desc>
      <group_list>
        <group group_id="E1">
          <title>RT+Tp</title>
          <description>Resistance training using electrical stimulation and ankle weights and Testosterone patches
Resistance Training and Testosterone Patches: We are going to activate the knee extensor muscle group to lift ankle weights over 16 weeks and we are going to provide Tp to improve anabolic profile.</description>
        </group>
        <group group_id="E2">
          <title>Testosterone Replacement Patches (Tp)</title>
          <description>Applying Testosterone patches
Testosterone Patches: The investigators will provide Tp patches for 16 weeks for patients with Spinal Cord Injury.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ashraf S. Gorgey</name_or_title>
      <organization>Hunter Holmes McGuire VA Medical Center</organization>
      <phone>8046755000 ext 3386</phone>
      <email>ashraf.gorgey@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

